Law360 | October 11, 2023
“In some respects, the judge’s decision to vacate provisions of HHS’ regulations concerning copay accumulators is a symptom of the lack of action by policymakers to address the high cost of certain prescription drugs in the commercial insurance market,” said Zachary Baron who directs the O’Neill Institute’s health policy and the law initiative at the Georgetown University Law Center.